(P-581) Racial/Ethnic Disparities of Renal Outcomes in People with HIV (PWH) on Tenofovir Alafenamide (TAF) Based Antiretroviral Treatment (ART) Regimens in the Real World

Thursday, October 17, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Samir K. Gupta, MD (he/him/his)

Professor of Medicine
Indiana University School of Medicine
Indianapolis, Indiana, United States

RC

Robert Canada, MD

University of Tennessee Health Science Center
Memphis, Tennessee, United States
SN

Sarjita Naik, PharmD, MPH

Gilead Sciences, Inc.
Foster City, California, United States
XH

Xiwen Huang, PhD

Gilead Sciences, Inc.
Foster City, California, United States
AW

Amy Weinberg, DNP, MS

Senior Director
Gilead Sciences, Inc.
Foster City, California, United States
LT

Lauren Temme, PharmD

Sr. Director, Medical Affairs
Gilead Sciences
Foster City, CA, United States
Li Tao, MD, PhD

Director
Gilead Sciences
Foster City, CA, United States
BC

Betty Chiang, MD

Gilead Sciences, Inc.
Foster City, California, United States
AC

Anand Chokkalingam, PhD

Clinical Research
Gilead
Foster City, California, United States
Jihad Slim, MD, FACP

Medical Director
Saint Michael’s Medical Center, Newark, NJ, USA
Newark, New Jersey, United States